Endoscopic Submucosal Dissection for Early Esophageal Adenocarcinoma: Low Rates of Metastases in Mucosal Cancers with Poor Differentiation.

endoscopic resection endoscopic submucosal dissection esophageal adenocarcinoma lymph node metastasis poor differentiation

Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
11 Mar 2024
Historique:
received: 12 10 2023
revised: 27 02 2024
accepted: 01 03 2024
medline: 14 3 2024
pubmed: 14 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

Endoscopic resection (ER) is accepted as standard treatment for intramucosal esophageal adenocarcinoma (EAC) with well or moderate differentiation. Poor differentiation (PD) is judged as a risk factor for lymph node metastasis (LNM) and surgery is recommended. However, the evidence for this recommendation is weak. Study aim was to analyze the clinical course of patients after ER of EAC with PD. Patients undergoing endoscopic submucosal dissection for EAC were included from 16 German centers. Inclusion criteria were PD in the resection specimen, R0 resection and endoscopic follow-up. Primary outcome was the metastasis rate during follow-up. Analysis was performed retrospectively in a prospectively collected database. 25 patients with PD as single risk factor (group A) and 15 patients with PD and additional risk factors (submucosal invasion and/or lymphovascular invasion) were included. The metastasis rate was was 1/25 (4.0%; 95%CI 0.4-17.2) in group A and 3/15 (20.0%; 95%CI 6.0-44.4%) in group B, respectively (p=0.293). The rate of EAC-associated deaths was 1/25 (4%; 95%CI 0.4-17.2%) versus 3/15 (20%; 95%CI 6.0-44.4%) in group B (p=0.293) while the overall death rate was 7/25 (28.0%; 95%CI 13.5-47.3%) versus 3/15 (20%; 95%CI 6.0-44.4%) (p=0.715). Median follow-up was 30 months (IQR 15-53). During long-term follow-up the risk of metastasis is low after ER of mucosal EAC with PD as single risk factor. A conservative approach seems justified in this small patient group. However, the treatment strategy has to be determined on an individualized basis until further prospective data are available.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Endoscopic resection (ER) is accepted as standard treatment for intramucosal esophageal adenocarcinoma (EAC) with well or moderate differentiation. Poor differentiation (PD) is judged as a risk factor for lymph node metastasis (LNM) and surgery is recommended. However, the evidence for this recommendation is weak. Study aim was to analyze the clinical course of patients after ER of EAC with PD.
PATIENTS AND METHODS METHODS
Patients undergoing endoscopic submucosal dissection for EAC were included from 16 German centers. Inclusion criteria were PD in the resection specimen, R0 resection and endoscopic follow-up. Primary outcome was the metastasis rate during follow-up. Analysis was performed retrospectively in a prospectively collected database.
RESULTS RESULTS
25 patients with PD as single risk factor (group A) and 15 patients with PD and additional risk factors (submucosal invasion and/or lymphovascular invasion) were included. The metastasis rate was was 1/25 (4.0%; 95%CI 0.4-17.2) in group A and 3/15 (20.0%; 95%CI 6.0-44.4%) in group B, respectively (p=0.293). The rate of EAC-associated deaths was 1/25 (4%; 95%CI 0.4-17.2%) versus 3/15 (20%; 95%CI 6.0-44.4%) in group B (p=0.293) while the overall death rate was 7/25 (28.0%; 95%CI 13.5-47.3%) versus 3/15 (20%; 95%CI 6.0-44.4%) (p=0.715). Median follow-up was 30 months (IQR 15-53).
CONCLUSIONS CONCLUSIONS
During long-term follow-up the risk of metastasis is low after ER of mucosal EAC with PD as single risk factor. A conservative approach seems justified in this small patient group. However, the treatment strategy has to be determined on an individualized basis until further prospective data are available.

Identifiants

pubmed: 38479623
pii: S0016-5107(24)00166-4
doi: 10.1016/j.gie.2024.03.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Andreas Probst (A)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany. Electronic address: andreas.probst@uk-augsburg.de.

Felix Kappler (F)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany.

Alanna Ebigbo (A)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany.

David Albers (D)

Department of Gastroenterology, Elisabeth-Krankenhaus Essen, Essen, Germany.

Siegbert Faiss (S)

Department of Gastroenterology, Sana Klinikum Lichtenberg, Berlin, Germany.

Ingo Steinbrück (I)

Department of Gastroenterology, Asklepios Klinik Barmbek, Hamburg, Germany; Department of Medicine and Gastroenterology, Evangelisches Diakoniekrankenhaus Freiburg, Freiburg, Germany.

Andreas Wannhoff (A)

Department of Gastroenterology, RKH Klinikum Ludwigsburg, Ludwigsburg, Germany.

Hans-Peter Allgaier (HP)

Department of Medicine and Gastroenterology, Evangelisches Diakoniekrankenhaus Freiburg, Freiburg, Germany.

Ulrike Denzer (U)

Department of Gastroenterology, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany.

Viktor Rempel (V)

Department of Gastroenterology, St. Anna Hospital Herne, Herne, Germany.

Roland Reinehr (R)

Department of Medicine and Gastroenterology, Elbe-Elster Klinikum, Herzberg, Germany.

Dani Dakkak (D)

Department of Gastroenterology, Elisabeth-Krankenhaus Essen, Essen, Germany.

Matthias Mende (M)

Department of Gastroenterology, Sana Klinikum Lichtenberg, Berlin, Germany.

Jürgen Pohl (J)

Department of Gastroenterology, Asklepios Klinik Altona, Hamburg, Germany.

Tina Schaller (T)

Pathology, Medical Faculty Augsburg, University of Augsburg, Germany.

Bruno Märkl (B)

Pathology, Medical Faculty Augsburg, University of Augsburg, Germany.

Anna Muzalyova (A)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany.

Carola Fleischmann (C)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital, Paracelsus Medical University Nuremberg, Nuremberg, Germany.

Helmut Messmann (H)

Department of Gastroenterology, University Hospital of Augsburg, Augsburg, Germany.

Classifications MeSH